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Abstract
Background: Diarrheal diseases have been seen in all geographical areas throughout the world. Therefore,
considering treatment, could be deemed a necessary action.
Objective: The aim of this study was to determine the antimicrobial effect of probiotic bacterial strains isolated
from different natural sources against 2 pathotypes of pathogenic E. coli.
Methods: This cross-sectional study of Martyr Chamran University of Ahvaz was carried out from December
2013 to July 2014. A total of 13 probiotic colonies isolated from 20 samples of traditional dairy products
including (yogurt, cheese, milk) and 20 samples of vegetables including carrots and cabbages (red and white) of
which 5 isolates were selected to evaluate the antimicrobial effect against 2 Escherichia coli pathotypes,
randomly. Antimicrobial effect was evaluated using two methods: disk diffusion and well diffusion tests and
measuring growth inhibition zones of probiotics against 2 pathotypes of pathogenic E. coli.
Results: Obtained results showed growth inhibition effects of all 5 probiotic strains against Escherichia coli
pathotypes in both used methods. All selected strains showed considerable antimicrobial effect on Escherichia
coli O157:H7 strain, but had no inhibitory effect against Enterohemorrhagic Escherichia coli.
Conclusion: This study demonstrated considerable antimicrobial effect against E. coli O157:H7 strain. Due to
this, characteristic and similar antimicrobial effects of probiotics bacteria, increasing use of the probiotics as a
natural and modern method for prevention of different diseases is recommended.
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1. Introduction
Probiotics are special microorganisms with important characteristics. They can tolerate bile salts and stomach
acidity. These microorganisms can be a part of the gut microflora with ability to bind to intestinal cells in
competition with pathogen microorganisms. They can produce antimicrobial compounds such as lactic acid, and
bacteriocin etc. (1). The term of probiotic is derived from Greek language meaning life. According to the latest
report of the Food and Agriculture Organization (FAO) and World Health Organization (WHO), probiotics are live
microorganisms whose adequate intake causes beneficial effects on health (2). Several studies demonstrated their
effects on prevention and treatment of many diseases (1). Intestinal microflora is very dependent on consumed food
type. Therefore, it can substitute harmful microorganisms with useful types. Probiotics promote the growth of
beneficial intestinal bacteria or reduce harmful microorganisms (3). Diarrhea is one of the causes of children’s
illness, and mortality in developing countries. After viruses, bacteria are the second causative agents in diarrhea.
Almost 30% of cases are bacterial with high treatment costs, E. coli is one of the main bacteria of intestinal
microflora (4). Intestinal pathogenic E. coli causes 8-10% of diarrhea cases in children (5). Isolation of E. coli
O157:H7 is more than other enteric pathogens especially Shigella in the United States (6). The Enterohemorrhagic
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Escherichia coli (EHEC) strains are discussed as causative agents of hemorrhagic colitis and hemolytic uremic
syndrome. Shiga-like toxin of this strain has verotoxic effects. Infective dose of E. coli O157:H7 is low and up to
100 bacteria causing disease (7). Recently, unprecedented outbreaks of E. coli O157:H7 infection happened in
Japan, Scotland and America and with other serotypes of EHEC in Europe and Australia, it seems, further
investigation in applying new techniques to prevent and control these bacteria are necessary (8). In developing
countries, as a major public health problem the main cause of diarrhea among children is Escherichia coli bacteria
(9). Nowadays, probiotics are consumed to inhibit pathogens and increase shelf life of foods. They release
antimicrobial compounds (such as lactic acid, bacteriocin and hydrogen peroxide) and compete with pathogens that
lead to increase the immune response of the host (1). Incidence of antibiotic resistance, loss of normal intestinal
flora, verotoxin induced by E. coli strains particularly as a result of taking antibiotics, needs novel therapeutic
methods (10). The aim of this study was to determine the antimicrobial effect of different isolated probiotics against
E. coli O157:H7 and pathogenic EHEC strains using two disk diffusion and well diffusion methods.
2. Material and Methods
2.1. Isolation and identification of bacteria
For separation of probiotic bacteria, 20 samples of traditional dairy products including (yogurt, cheese and milk) and
20 samples of vegetables including carrots and cabbages (red and white) were collected from different areas of
Ahvaz city as well as 10 samples of Tarkhineh (traditional food rich of variety of specific probiotics) that were
collected from Khorramabad (West of Iran). MRS Broth and MRS Agar mediums (Merck, Germany) were used for
their separation of prepared samples. At first 1 gr of each sample (dairy, vegetables, Tarkhineh) (carrots and cabbage
samples were crushed in a sterile mortar) were weighed, dissolved in 10 ml MRS Broth medium then incubated at
37 °C and shaken  at 140 rpm for 24 hours (8). Serial dilution was prepared (to 10-3) and further purification was
performed under sterile conditions by culturing in MRS Agar medium. All isolated colonies were identified using
biochemical tests (gram staining, catalase test, oxidase test, growth at different temperatures and carbohydrates
fermentations and motility) and molecular assessment (polymerase chain reaction test) (11). General primers
capable proliferations of 16 rRNA genes were used to perform PCR test (Takapoozist, Iran). Primer’s sequencing
was shown in Table 1. To confirm genome replication and determine fragment size, PCR protocol was followed on
agarose gel. Gel extraction kit was used for extraction 1500-bp single bands. To determine sequencing, purified
genes were sent to Takapoozist Company. The results were arranged using BioEdit software and were evaluated in
the National Center for Biotechnology Information (NCBI) website using Blast software. Phylogenetic trees of
identified isolates were drawn using mega-4 software.
Table 1. Selected primers for polymerase chain reaction
Primers type Primers sequences (5′ to 3′) Product size (bp)
Forward primer (FP1) 5′- AGAGTTTGATCATGGCTCAG-3′ 20 bases
Reverse primer (RP1) 5′-TACGGYTACCTTGTTACGACTT-3′ 22 bases
2.2. Supernatant preparing of bacteria
After isolation and molecular identification of isolates, 5 strains of probiotic bacteria were selected, randomly. All
selected isolates were cultured in MRS Broth and incubated at 37 °C for 24 hours to obtain 0.5 McFarland turbidity
(1.5×108 cfu/ml). Bacterial supernatant was prepared by centrifuge of isolates culture suspension for 25 min at 4 °C
and 3500 rpm.
2.3. Preparation of pathogenic bacteria
Two pathogenic strains of E. coli including EHEC (Enterohemorrhagic E. coli) and E. coli O157:H7 strains were
provided by the microbiology department of Tarbiat Modares University in Tehran. TSB medium was used for
culturing strains at 37 °C.
2.4. Evaluation of antimicrobial activity of probiotic bacteria
Mueller-Hinton Agar (MHA) was used to investigate antimicrobial activity of isolated probiotic bacteria. For this
purpose, inhibitory and antagonistic effects of probiotic bacteria on 2 pathotype of E. coli was determined using two
methods: Disk Diffusion Agar and Well Diffusion Agar methods. All tests were repeated twice.
2.4.1. Disk Diffusion Agar method:
Sterile blank disks (8 mm diameter) were smeared with supernatant of 5 probiotic bacteria for 5 minutes. In order to
dry them, all disks were placed at 37 °C for 15 minutes. The suspension of pathogenic bacteria was spread on plates
containing MHA medium. Impregnated discs with supernatant were placed on MHA with a 2.5 cm distance. All
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plates were incubated at 37 °C and after 24 hours, growth inhibition zone of probiotics against pathotypes of E. coli
were measured by a ruler.
2.4.2. Well Diffusion Agar method:
Suspension of pathogen bacteria cultured in TSB were spread on plates containing MHA, then 10μl of each
probiotic supernatant was spilled to punch wells in the plates.  After incubation at 37 °C for 24 hours, growth
inhibition zone was measured (12). In comparison, antimicrobial effects of 5 antibiotics on 4 pathotype E. coli were
investigated including: nalidixic acid, penicillin, cephalosporin, gentamicin and novobiocin. For this purpose, the
suspension of pathogenic bacteria was spread on TSA plates and antibiotic discs were placed with a distance (2.5
cm) on them. After incubation at 37 °C for 24 hours, growth inhibition zone was measured with a ruler.
3. Results
A total of 13 probiotic colonies isolated from samples of which, 5 isolates were selected to evaluate the
antimicrobial effect against 4 E. coli pathotypes, randomly, that were subjected to biochemical and molecular
identification. Identified probiotics strains were Lactobacillus plantarum, Lactobacillus Gasseri, Enterococcus
faecium, Bacillus subtilis, Weissella paramesenteroides. Obtained results showed growth inhibition effects of all 5
probiotic strains on E. coli O157:H7 in both used methods. Growth inhibition zone was not seen against EHEC
Pathotype in both methods. Mean growth inhibition zone of 5 probiotic strain against E. coli O157:H7 pathotype in
disk diffusion and well diffusion methods were 9-12 mm and 6-9 mm, respectively. In comparison, inhibition zones
in disk diffusion were considerable. Results of growth inhibition zone of two disk diffusion and well diffusion
methods were shown in Tables 2 and 3, respectively. Among five probiotic strains, Lactobacillus plantarum and
Weissella paramesenteroides created growth inhibition zone in both methods against E. coli O157:H7 strain (Figure
1). Table 4 shows growth inhibition zone of used antibiotics against two pathotypes. Obtained results showed that
nalidixic acid antibiotic had a significant inhibitory effect on both pathotypes EHEC (20 mm) and O157:H7 (22
mm) (Figure 1).
Table 2. Growth Inhibition zone (mm) of selected probiotic strains against 2 pathotypes of E. coli (Disk diffusion method)
Probiotic Pathogen
O157:H7 EHEC
L.plantarum 9 -
L.gasseri 9 -
E. fascium 9 -
B. subtilis 12 -
W. paramesenteroides 10 -
Table 3. Growth Inhibition zone (mm) of selected probiotic strains against 2 pathotypes of E. coli (well diffusion method)
Probiotic Pathogen
O157:H7 EHEC
L.plantarum 6 -
L.gasseri - -
E. fascium - -
B. subtilis - -
W. paramesenteroides 9 -
Table 4. Growth inhibitory zone of selected antibiotics against 2 pathotypes of E. coli (Antibiogram)
Antibiotic Pathogen
O157:H7 EHEC
Nevobiocin - -
Penicillin - -
Nalidixic acid 22 20
Cephalosporins - -
Gentamycin - -
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Figure 1. Left: inhibition zone on the strain O157:H7 in disc method; Right: inhibition zone on the strain O157:H7
by antibiotic discs
4. Discussion and conclusions
Selected probiotics particularly Lactobacillus plantarum and Weissella paramesenteroides had good inhibitory
effects against E. coli O157:H7 pathotype. Probiotics had no inhibitory effect on the EHEC strain. Infectious
diarrhea diseases are characterized as the second cause of death in children younger than 5 years among infectious
diseases (13). Approximately one billion cases of diarrhea occur in children younger than 5 years, annually, of
which around 4.5 million lose their lives. Many studies have been conducted to evaluate pathogens causing diarrhea,
as well as innovative and effective treatment methods worldwide. Comparing the results, shows variable incidences
in different regions. Acute infectious diarrhea is the fifth cause of death and 16.2% of infectious diseases in Iran
(14). The fifth cause of acute infectious diarrhea that can lead to death due to infectious diseases in Iran accounted
for 16.2 percent of the data (18). Causes of diarrheal diseases are varied between developing and developed
countries, considerably -in range. Viruses are important agents of diarrheal diseases in developed countries, while
bacterial agents such as ETEC, Campylobacter species, Shigella and Salmonella spp are causing agents in most
developing countries (15, 16). Diarrheagenic E. coli is known as the most important causative agent of endemic and
epidemic diarrhea in the world (17). Zeighami et al. and Pourakbari et al. recorded that EHEC strain is the causative
agent in 12.1 % and 17 % of diarrheal diseases in children younger than 5 years, respectively (18,19). Erdogan et al.
in Turkey, reported E. coli O157:H7 in 1% of diarrheal patients (10). Many studies showed growth inhibitory effects
of probiotics against different pathogens, Ota et al. reported that yogurt consumption causes intestinal colonization
of probiotic bacteria such as Lactobacillus, and provided conditions to prevent colonization of EHEC. They
observed that different lactobacilli culture supernatant can prevent growth of different pathogens such as Listeria
monocytogenes, Salmonella, Shigella and Staphylococcus aureus (20). Hassanzadazar et al. showed growth
inhibitory effects of probiotic Lactobacillus casei and Enterococcus fascium against Listeria monocytogenesis,
Escherichia coli bacillus cereus and Salmonella enteritidis (21, 22). Obtained results of the present study showed
growth inhibitory effects of 5 probiotic bacteria against E. coli O157:H7 strain. Similar studies confirmed
antimicrobial effects of culture supernatant of probiotics, for example Hirano et al showed growth inhibitory effects
of L. plantarum and Lactobacillus curvatus against different pathogens with well diffusion method (23). Matsusaki
studied growth inhibitory effects of probiotic Lactobacillus with colony count method (24). Based on the results of
this study, present probiotic bacteria in natural resources can be used for inhibition and reduction of pathogens,
including enteric pathogens and antibacterial effects of their metabolites are active and stable under different
conditions of temperature and acidity.
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